Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Age-dependent immune responses and immune protection after avian coronavirus vaccination.

van Ginkel FW, Padgett J, Martinez-Romero G, Miller MS, Joiner KS, Gulley SL.

Vaccine. 2015 May 28;33(23):2655-61. doi: 10.1016/j.vaccine.2015.04.026. Epub 2015 Apr 21.

PMID:
25910920
2.

Immunoglobulin A as an early humoral responder after mucosal avian coronavirus vaccination.

Orr-Burks N, Gulley SL, Toro H, van Ginkel FW.

Avian Dis. 2014 Jun;58(2):279-86.

PMID:
25055633
3.

S1 of distinct IBV population expressed from recombinant adenovirus confers protection against challenge.

Toro H, Zhang JF, Gallardo RA, van Santen VL, van Ginkel FW, Joiner KS, Breedlove C.

Avian Dis. 2014 Jun;58(2):211-5.

PMID:
25055623
4.

Cell-mediated immune responses in the head-associated lymphoid tissues induced to a live attenuated avian coronavirus vaccine.

Gurjar RS, Gulley SL, van Ginkel FW.

Dev Comp Immunol. 2013 Dec;41(4):715-22. doi: 10.1016/j.dci.2013.08.002. Epub 2013 Aug 13.

PMID:
23948147
5.
6.

Infectious bronchitis virus subpopulations in vaccinated chickens after challenge.

Toro H, Pennington D, Gallardo RA, van Santen VL, van Ginkel FW, Zhang J, Joiner KS.

Avian Dis. 2012 Sep;56(3):501-8.

PMID:
23050466
7.

Avian influenza adenovirus-vectored in ovo vaccination: target embryo tissues and combination with Marek's disease vaccine.

Breedlove C, Minc JK, Tang DC, van Santen VL, van Ginkel FW, Toro H.

Avian Dis. 2011 Dec;55(4):667-73.

PMID:
22312988
8.

Conjunctiva-associated lymphoid tissue in avian mucosal immunity.

van Ginkel FW, Gulley SL, Lammers A, Hoerr FJ, Gurjar R, Toro H.

Dev Comp Immunol. 2012 Feb;36(2):289-97. doi: 10.1016/j.dci.2011.04.012. Epub 2011 May 27.

PMID:
21641931
9.

Avian influenza mucosal vaccination in chickens with replication-defective recombinant adenovirus vaccine.

Toro H, Suarez DL, Tang DC, van Ginkel FW, Breedlovea C.

Avian Dis. 2011 Mar;55(1):43-7.

PMID:
21500634
10.

Effects of phytase supplementation in broiler diets on a natural Eimeria challenge in naive and vaccinated birds.

Shaw AL, van Ginkel FW, Macklin KS, Blake JP.

Poult Sci. 2011 Apr;90(4):781-90. doi: 10.3382/ps.2010-01158.

PMID:
21406363
11.

An autologous dendritic cell canine mammary tumor hybrid-cell fusion vaccine.

Bird RC, Deinnocentes P, Church Bird AE, van Ginkel FW, Lindquist J, Smith BF.

Cancer Immunol Immunother. 2011 Jan;60(1):87-97. doi: 10.1007/s00262-010-0921-2. Epub 2010 Nov 11.

PMID:
21069323
12.

Avian influenza vaccination in chickens and pigs with replication-competent adenovirus-free human recombinant adenovirus 5.

Toro H, van Ginkel FW, Tang DC, Schemera B, Rodning S, Newton J.

Avian Dis. 2010 Mar;54(1 Suppl):224-31.

13.

Pathogenicity of infectious bursal disease virus variant AL2 in young chickens.

Toro H, Effler JC, Hoerr FJ, van Ginkel FW.

Avian Dis. 2009 Mar;53(1):78-82.

PMID:
19432007
15.

Neural stem/progenitor cells modulate immune responses by suppressing T lymphocytes with nitric oxide and prostaglandin E2.

Wang L, Shi J, van Ginkel FW, Lan L, Niemeyer G, Martin DR, Snyder EY, Cox NR.

Exp Neurol. 2009 Mar;216(1):177-83. doi: 10.1016/j.expneurol.2008.11.017. Epub 2008 Dec 9.

PMID:
19109951
16.

Long-term correction of inhibitor-prone hemophilia B dogs treated with liver-directed AAV2-mediated factor IX gene therapy.

Niemeyer GP, Herzog RW, Mount J, Arruda VR, Tillson DM, Hathcock J, van Ginkel FW, High KA, Lothrop CD Jr.

Blood. 2009 Jan 22;113(4):797-806. doi: 10.1182/blood-2008-10-181479. Epub 2008 Oct 28.

17.

Induction of mucosal immunity in the avian Harderian gland with a replication-deficient Ad5 vector expressing avian influenza H5 hemagglutinin.

van Ginkel FW, Tang DC, Gulley SL, Toro H.

Dev Comp Immunol. 2009;33(1):28-34. doi: 10.1016/j.dci.2008.07.018.

18.

Temporal delay of peak T-cell immunity determines Chlamydia pneumoniae pulmonary disease in mice.

Wang C, van Ginkel FW, Kim T, Li D, Li Y, Dennis JC, Kaltenboeck B.

Infect Immun. 2008 Nov;76(11):4913-23. doi: 10.1128/IAI.00569-08. Epub 2008 Aug 25.

19.

Immunity to a self-derived, channel-forming peptide in the respiratory tract.

van Ginkel FW, Iwamoto T, Schultz BD, Tomich JM.

Clin Vaccine Immunol. 2008 Feb;15(2):260-6. Epub 2007 Dec 19.

20.

Pathogenesis of infectious bronchitis virus in vaccinated chickens of two different major histocompatibility B complex genotypes.

Joiner KS, Hoerr FJ, Ewald SJ, van Santen VL, Wright JC, van Ginkel FW, Toro H.

Avian Dis. 2007 Sep;51(3):758-63.

PMID:
17992938
21.

A novel role for defensins in intestinal homeostasis: regulation of IL-1beta secretion.

Shi J, Aono S, Lu W, Ouellette AJ, Hu X, Ji Y, Wang L, Lenz S, van Ginkel FW, Liles M, Dykstra C, Morrison EE, Elson CO.

J Immunol. 2007 Jul 15;179(2):1245-53.

22.

Bacillus anthracis edema toxin acts as an adjuvant for mucosal immune responses to nasally administered vaccine antigens.

Duverger A, Jackson RJ, van Ginkel FW, Fischer R, Tafaro A, Leppla SH, Fujihashi K, Kiyono H, McGhee JR, Boyaka PN.

J Immunol. 2006 Feb 1;176(3):1776-83.

23.

Nasal colonization with Streptococcus pneumoniae includes subpopulations of surface and invasive pneumococci.

Briles DE, Novak L, Hotomi M, van Ginkel FW, King J.

Infect Immun. 2005 Oct;73(10):6945-51.

24.

Enterotoxin-based mucosal adjuvants alter antigen trafficking and induce inflammatory responses in the nasal tract.

van Ginkel FW, Jackson RJ, Yoshino N, Hagiwara Y, Metzger DJ, Connell TD, Vu HL, Martin M, Fujihashi K, McGhee JR.

Infect Immun. 2005 Oct;73(10):6892-902.

25.

A novel adjuvant for mucosal immunity to HIV-1 gp120 in nonhuman primates.

Yoshino N, Lü FX, Fujihashi K, Hagiwara Y, Kataoka K, Lu D, Hirst L, Honda M, van Ginkel FW, Takeda Y, Miller CJ, Kiyono H, McGhee JR.

J Immunol. 2004 Dec 1;173(11):6850-7.

26.

Pneumococcal carriage results in ganglioside-mediated olfactory tissue infection.

van Ginkel FW, McGhee JR, Watt JM, Campos-Torres A, Parish LA, Briles DE.

Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):14363-7. Epub 2003 Nov 10. Erratum in: Proc Natl Acad Sci U S A. 2004 Apr 27;101(17):6834.

27.

Immunizations with pneumococcal surface protein A and pneumolysin are protective against pneumonia in a murine model of pulmonary infection with Streptococcus pneumoniae.

Briles DE, Hollingshead SK, Paton JC, Ades EW, Novak L, van Ginkel FW, Benjamin WH Jr.

J Infect Dis. 2003 Aug 1;188(3):339-48. Epub 2003 Jul 14.

PMID:
12870114
28.

Delayed lupus onset in (NZB x NZW)F1 mice expressing a human C-reactive protein transgene.

Szalai AJ, Weaver CT, McCrory MA, van Ginkel FW, Reiman RM, Kearney JF, Marion TN, Volanakis JE.

Arthritis Rheum. 2003 Jun;48(6):1602-11.

29.

A nontoxic chimeric enterotoxin adjuvant induces protective immunity in both mucosal and systemic compartments with reduced IgE antibodies.

Kweon MN, Yamamoto M, Watanabe F, Tamura S, Van Ginkel FW, Miyauchi A, Takagi H, Takeda Y, Hamabata T, Fujihashi K, McGhee JR, Kiyono H.

J Infect Dis. 2002 Nov 1;186(9):1261-9. Epub 2002 Oct 3.

PMID:
12402195
30.

A dilemma for mucosal vaccination: efficacy versus toxicity using enterotoxin-based adjuvants.

Fujihashi K, Koga T, van Ginkel FW, Hagiwara Y, McGhee JR.

Vaccine. 2002 Jun 7;20(19-20):2431-8. Review.

PMID:
12057597
31.

A revisit of mucosal IgA immunity and oral tolerance.

Fujihashi K, Kato H, van Ginkel FW, Koga T, Boyaka PN, Jackson RJ, Kato R, Hagiwara Y, Etani Y, Goma I, Fujihashi K, Kiyono H, McGhee JR.

Acta Odontol Scand. 2001 Oct;59(5):301-8. Review.

PMID:
11680650
32.

A clinical inflammatory syndrome attributable to aerosolized lipid-DNA administration in cystic fibrosis.

Ruiz FE, Clancy JP, Perricone MA, Bebok Z, Hong JS, Cheng SH, Meeker DP, Young KR, Schoumacher RA, Weatherly MR, Wing L, Morris JE, Sindel L, Rosenberg M, van Ginkel FW, McGhee JR, Kelly D, Lyrene RK, Sorscher EJ.

Hum Gene Ther. 2001 May 1;12(7):751-61.

PMID:
11339892
33.

Oral QS-21 requires early IL-4 help for induction of mucosal and systemic immunity.

Boyaka PN, Marinaro M, Jackson RJ, van Ginkel FW, Cormet-Boyaka E, Kirk KL, Kensil CR, McGhee JR.

J Immunol. 2001 Feb 15;166(4):2283-90.

34.

Heterosubtypic immunity to influenza A virus infection requires B cells but not CD8+ cytotoxic T lymphocytes.

Nguyen HH, van Ginkel FW, Vu HL, McGhee JR, Mestecky J.

J Infect Dis. 2001 Feb 1;183(3):368-76. Epub 2000 Dec 20.

PMID:
11133367
35.

Cutting edge: the mucosal adjuvant cholera toxin redirects vaccine proteins into olfactory tissues.

van Ginkel FW, Jackson RJ, Yuki Y, McGhee JR.

J Immunol. 2000 Nov 1;165(9):4778-82.

36.

Complement-dependent acute-phase expression of C-reactive protein and serum amyloid P-component.

Szalai AJ, van Ginkel FW, Wang Y, McGhee JR, Volanakis JE.

J Immunol. 2000 Jul 15;165(2):1030-5.

37.
38.

Vaccines for mucosal immunity to combat emerging infectious diseases.

van Ginkel FW, Nguyen HH, McGhee JR.

Emerg Infect Dis. 2000 Mar-Apr;6(2):123-32. Review.

39.

Expression of recombinant enterotoxigenic Escherichia coli colonization factor antigen I by Salmonella typhimurium elicits a biphasic T helper cell response.

Pascual DW, Hone DM, Hall S, van Ginkel FW, Yamamoto M, Walters N, Fujihashi K, Powell RJ, Wu S, Vancott JL, Kiyono H, McGhee JR.

Infect Immun. 1999 Dec;67(12):6249-56.

40.

Partial IgA-deficiency with increased Th2-type cytokines in TGF-beta 1 knockout mice.

van Ginkel FW, Wahl SM, Kearney JF, Kweon MN, Fujihashi K, Burrows PD, Kiyono H, McGhee JR.

J Immunol. 1999 Aug 15;163(4):1951-7.

41.

Strategies for mucosal vaccine development.

Boyaka PN, Marinaro M, Vancott JL, Takahashi I, Fujihashi K, Yamamoto M, van Ginkel FW, Jackson RJ, Kiyono H, McGhee JR.

Am J Trop Med Hyg. 1999 Apr;60(4 Suppl):35-45. Review.

PMID:
10344675
42.

Heterosubtypic immunity to lethal influenza A virus infection is associated with virus-specific CD8(+) cytotoxic T lymphocyte responses induced in mucosa-associated tissues.

Nguyen HH, Moldoveanu Z, Novak MJ, van Ginkel FW, Ban E, Kiyono H, McGhee JR, Mestecky J.

Virology. 1999 Feb 1;254(1):50-60.

43.

Measurement of HIV-1 Specific and Total Antibody Secreting Cells by ELISPOT.

van Ginkel FW, Vancott JL, Kaminski R, Vancott TC.

Methods Mol Med. 1999;17:283-92. doi: 10.1385/0-89603-369-4:283.

PMID:
21380680
44.

Testosterone and IL-6 requirements for human C-reactive protein gene expression in transgenic mice.

Szalai AJ, van Ginkel FW, Dalrymple SA, Murray R, McGhee JR, Volanakis JE.

J Immunol. 1998 Jun 1;160(11):5294-9.

45.

Adenoviral gene delivery elicits distinct pulmonary-associated T helper cell responses to the vector and to its transgene.

van Ginkel FW, McGhee JR, Liu C, Simecka JW, Yamamoto M, Frizzell RA, Sorscher EJ, Kiyono H, Pascual DW.

J Immunol. 1997 Jul 15;159(2):685-93.

PMID:
9218583
46.

Mucosal immunization with DNA encoding influenza hemagglutinin.

Ban EM, van Ginkel FW, Simecka JW, Kiyono H, Robinson HL, McGhee JR.

Vaccine. 1997 Jun;15(8):811-3. No abstract available.

PMID:
9234521
47.

A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity.

Yamamoto S, Kiyono H, Yamamoto M, Imaoka K, Fujihashi K, Van Ginkel FW, Noda M, Takeda Y, McGhee JR.

Proc Natl Acad Sci U S A. 1997 May 13;94(10):5267-72.

48.

A T cell/B cell/epithelial cell internet for mucosal inflammation and immunity.

Fujihashi K, Kweon MN, Kiyono H, VanCott JL, van Ginkel FW, Yamamoto M, McGhee JR.

Springer Semin Immunopathol. 1997;18(4):477-94. Review. No abstract available.

PMID:
9144866
50.

Systematic analysis of repeated gene delivery into animal lungs with a recombinant adenovirus vector.

Dong JY, Wang D, Van Ginkel FW, Pascual DW, Frizzell RA.

Hum Gene Ther. 1996 Feb 10;7(3):319-31.

PMID:
8835219

Supplemental Content

Loading ...
Support Center